CardieX Limited Acquires Wearable Sensor Startup Blumio, Inc.
November 15, 2022
CardieX Limited (ASX: CDX) acquired the assets of Silicon Valley–based Blumio, Inc., bringing Blumio's cardiovascular wearable sensor algorithms and data analytics into CardieX's CONNEQT and ATCOR product ecosystem. Blumio's CEO Catherine Liao and Head of Product Steve Braaten joined CardieX as part of the transaction; financial terms were not disclosed.
- Buyers
- CardieX Limited
- Targets
- Blumio, Inc.
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
WearLinq Acquires AMI Cardiac Monitoring to Expand Nationwide Clinical Services
May 21, 2024
Healthcare Services
WearLinq has acquired AMI Cardiac Monitoring, LLC to integrate AMI’s 33+ years of ambulatory cardiac monitoring expertise with WearLinq’s FDA 510(k)-cleared eWave 6-lead wearable ECG device. The acquisition expands WearLinq’s clinical services footprint across all 50 U.S. states and strengthens its diagnostic and remote-monitoring capabilities for cardiology providers and patients.
-
Kardigan Acquires Prolaio
March 27, 2025
Data & Analytics
Kardigan has acquired Prolaio, a Chicago-based clinical intelligence company, to integrate Prolaio's cardiovascular data, FDA-cleared monitoring software, and analytics into Kardigan's cardiac R&D platform. The acquisition gives Kardigan access to a large curated CV dataset and analytics capabilities intended to accelerate and optimize its cardiovascular drug development programs.
-
StemBioSys Acquires Majority Stake in Cartox
January 8, 2020
Biotechnology
San Antonio-based StemBioSys acquired a majority stake in Ann Arbor startup Cartox, obtaining control with plans to purchase the remaining equity subject to milestones. The deal brings Cartox's cardiotoxicity imaging and assay capabilities together with StemBioSys's CELLvo extracellular matrix technology to accelerate commercial development of pre-clinical cardiac safety and efficacy screening solutions.
-
Cardio Diagnostics Holdings Goes Public via Business Combination with Mana Capital Acquisition Corp.
October 26, 2022
Biotechnology
Cardio Diagnostics Holdings, Inc., a precision cardiovascular diagnostics company using epigenetics and AI, completed a business combination with special purpose acquisition company Mana Capital Acquisition Corp. The combined company began trading on the Nasdaq under the ticker symbols CDIO and CDIOW, providing Cardio with public-market access and capital to commercialize its epigenetics-based cardiovascular tests.
-
EMK Capital Acquires Cardo Systems
April 6, 2021
Consumer Products
EMK Capital has acquired Cardo Systems from Fortissimo Capital and founder Dr. Abraham Glezerman. Cardo, an Israel-headquartered designer and manufacturer of wireless communication devices for motorcycle riders, skiers and other groups in motion, employs over 100 people and sells products in more than 80 countries; financial terms were not disclosed.
-
Circle Cardiovascular Imaging Acquires Corstem Inc.
February 7, 2019
Healthcare Services
Circle Cardiovascular Imaging Inc. has acquired Montreal-based AI cardiac imaging developer Corstem Inc. Corstem’s automatic, fully-quantitative myocardial perfusion technology will be integrated into Circle’s cvi42 platform to expand its cardiac MRI perfusion capabilities and accelerate global clinical deployment.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.